TRIAL IN PROGRESS UPDATE ON ENGOTCX8/GOG-3024/INNOVATV 205: ADDITION OF A NEW COHORT USING FIRST-LINE TISOTUMAB VEDOTIN plus PEMBROLIZUMAB plus CARBOPLATIN - BEVACIZUMAB IN RECURRENTIMETASTATIC CERVICAL CANCER
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined